SOPHiA GENETICS SA (SOPH) Tops Q4 EPS by 17c

SOPHiA GENETICS SA (NASDAQ: SOPH) reported Q4 EPS of ($0.17), $0.17 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $13.4 million versus the consensus estimate of $12.92 million.

For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.

You May Also Be Interested In

• Piper Sandler defends Oracle ahead of earnings, sees $2.2 billion OCI upside
• Vontier completes sale of Teletrac Navman for $220 million
• Raymond James cuts Delta and JetBlue ratings ahead of Q2 earnings